{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:21:46Z","timestamp":1786980106230,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013003","name":"Universit\u00e0 degli Studi di Cagliari","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013003","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This case series examined the safety and effectiveness of hysteroscopic myolysis using laser-induced interstitial thermo-therapy (LITT) for treating heavy menstrual bleeding (HMB) in premenopausal women with FIGO type 1 or 2 uterine fibroids, not planning for future fertility. Additionally, a comprehensive review of innovative, minimally invasive, incisionless myolysis techniques was conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Women with HMB, sonographically diagnosed with a single FIGO type 1 or 2 fibroid, underwent hysteroscopic myolysis using the Leonardo\n                      <jats:sup>\u00ae<\/jats:sup>\n                      diode laser. Effectiveness was assessed via transvaginal ultrasound measurement of myoma size, volume and vascularization pre and post-procedure. Moreover, we also evaluated any improvements in symptoms using the Pictorial Blood Loss Assessment Chart (PBAC score) scores.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The procedure resulted in significant HMB reductions and noticeable fibroid size, volume, and vascularization decrease in all three patients, with no reported complications. The literature review revealed both advantages and limitations of the minimally invasive, incisionless myolysis techniques.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hysteroscopic laser myolysis is a safe and effective therapeutic intervention for patients experiencing HMB, diagnosed with FIGO type 1 or 2 fibroids, and not planning for future fertility. The procedure resulted in significant reductions in menstrual blood loss and fibroid size. Despite the promising results, it is essential to note the limitations of this report, including its case series design, a small number of patients, and a short follow-up period. Further research is necessary to confirm these results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00404-023-07218-y","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T10:02:17Z","timestamp":1697191337000},"page":"949-959","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Hysteroscopic diode laser myolysis: from a case series to literature review of incisionless myolysis techniques for managing heavy menstrual bleeding in premenopausal women"],"prefix":"10.1007","volume":"309","author":[{"given":"Salvatore Giovanni","family":"Vitale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1022-0958","authenticated-orcid":false,"given":"Stefania","family":"Saponara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda","family":"Sicilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Klari\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Sorrentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio Nicola","family":"D\u2019Alterio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Angioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"key":"7218_CR1","first-page":"0814","volume":"2015","author":"A Lethaby","year":"2015","unstructured":"Lethaby A, Vollenhoven B (2015) Fibroids (uterine myomatosis, leiomyomas). BMJ Clin Evid 2015:0814","journal-title":"BMJ Clin Evid"},{"key":"7218_CR2","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/HUMUPD\/DMW023","volume":"22","author":"J Donnez","year":"2016","unstructured":"Donnez J, Dolmans MM (2016) Uterine fibroid management: from the present to the future. Hum Reprod Update 22:665. https:\/\/doi.org\/10.1093\/HUMUPD\/DMW023","journal-title":"Hum Reprod Update"},{"key":"7218_CR3","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.2174\/1381612826666210101152820","volume":"27","author":"S Angioni","year":"2021","unstructured":"Angioni S, D\u2019Alterio MN, Daniilidis A (2021) Highlights on medical treatment of uterine fibroids. Curr Pharm Des 27:3821\u20133832. https:\/\/doi.org\/10.2174\/1381612826666210101152820","journal-title":"Curr Pharm Des"},{"key":"7218_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1067\/mob.2003.99","volume":"188","author":"DD Baird","year":"2003","unstructured":"Baird DD, Dunson DB, Hill MC et al (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188:100\u2013107. https:\/\/doi.org\/10.1067\/mob.2003.99","journal-title":"Am J Obstet Gynecol"},{"key":"7218_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/GRF.0000000000000287","volume":"60","author":"LN Valentine","year":"2017","unstructured":"Valentine LN, Bradley LD (2017) Hysteroscopy for abnormal uterine bleeding and fibroids. Clin Obstet Gynecol 60:231\u2013244. https:\/\/doi.org\/10.1097\/GRF.0000000000000287","journal-title":"Clin Obstet Gynecol"},{"key":"7218_CR6","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1056\/NEJMRA1209993","volume":"369","author":"SE Bulun","year":"2013","unstructured":"Bulun SE (2013) Uterine fibroids. N Engl J Med 369:1344\u20131355. https:\/\/doi.org\/10.1056\/NEJMRA1209993","journal-title":"N Engl J Med"},{"key":"7218_CR7","doi-asserted-by":"publisher","first-page":"818243","DOI":"10.3389\/FRPH.2022.818243","volume":"4","author":"O Uimari","year":"2022","unstructured":"Uimari O, Subramaniam KS, Vollenhoven B, Tapmeier TT (2022) Uterine fibroids (Leiomyomata) and heavy menstrual bleeding. Front Reprod Heal 4:818243. https:\/\/doi.org\/10.3389\/FRPH.2022.818243","journal-title":"Front Reprod Heal"},{"key":"7218_CR8","unstructured":"National Institute for Health and Excellence (UK) (2021). NICE Guideline [NG88]. Heavy menstrual bleeding: assessment and management. https:\/\/www.nice.org.uk\/guidance\/ng88. Accessed 10 Feb 2023."},{"key":"7218_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2147\/IJWH.S15710","volume":"3","author":"N Duhan","year":"2011","unstructured":"Duhan N (2011) Current and emerging treatments for uterine myoma\u2013an update. Int J Womens Health 3:231. https:\/\/doi.org\/10.2147\/IJWH.S15710","journal-title":"Int J Womens Health"},{"key":"7218_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3109\/09513590.2013.863861","volume":"30","author":"P Litta","year":"2014","unstructured":"Litta P, Conte L, De Marchi F et al (2014) Pregnancy outcome after hysteroscopic myomectomy. Gynecol Endocrinol 30:149\u2013152. https:\/\/doi.org\/10.3109\/09513590.2013.863861","journal-title":"Gynecol Endocrinol"},{"key":"7218_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/J.BPOBGYN.2015.11.013","volume":"34","author":"E Zupi","year":"2016","unstructured":"Zupi E, Centini G, Sabbioni L et al (2016) Nonsurgical alternatives for uterine fibroids. Best Pract Res Clin Obstet Gynaecol 34:122\u2013131. https:\/\/doi.org\/10.1016\/J.BPOBGYN.2015.11.013","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"7218_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/09513590.2019.1648419","volume":"36","author":"G Giarr\u00e8","year":"2019","unstructured":"Giarr\u00e8 G, Franchini M, Castellacci E et al (2019) Ulipristal acetate in symptomatic uterine fibroids. A real-world experience in a multicentric Italian study. Gynecol Endocrinol 36:171\u2013174. https:\/\/doi.org\/10.1080\/09513590.2019.1648419","journal-title":"Gynecol Endocrinol"},{"key":"7218_CR13","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/RCS.1542","volume":"10","author":"N Pluchino","year":"2014","unstructured":"Pluchino N, Litta P, Freschi L et al (2014) Comparison of the initial surgical experience with robotic and laparoscopic myomectomy. Int J Med Robot Comput Assist Surg 10:208\u2013212. https:\/\/doi.org\/10.1002\/RCS.1542","journal-title":"Int J Med Robot Comput Assist Surg"},{"key":"7218_CR14","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1007\/s43032-021-00722-z","volume":"29","author":"J Zhang","year":"2022","unstructured":"Zhang J, Go VA, Blanck JF et al (2022) A systematic review of minimally invasive treatments for uterine fibroid-related bleeding. Reprod Sci 29:2786\u20132809. https:\/\/doi.org\/10.1007\/s43032-021-00722-z","journal-title":"Reprod Sci"},{"key":"7218_CR15","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/01.GRF.0000211961.91616.78","volume":"49","author":"E Zupi","year":"2006","unstructured":"Zupi E, Sbracia M, Marconi D, Munro MG (2006) Myolysis of uterine fibroids: is there a role? Clin Obstet Gynecol 49:821\u2013833. https:\/\/doi.org\/10.1097\/01.GRF.0000211961.91616.78","journal-title":"Clin Obstet Gynecol"},{"key":"7218_CR16","first-page":"636","volume":"37","author":"HA Goldfarb","year":"1992","unstructured":"Goldfarb HA (1992) Nd:YAG laser laparoscopic coagulation of symptomatic myomas. J Reprod Med 37:636\u2013638","journal-title":"J Reprod Med"},{"key":"7218_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1089\/gyn.1993.9.95","volume":"9","author":"M Nisolle","year":"1993","unstructured":"Nisolle M, Smets M, Malvaux V et al (1993) Laparoscopic myolysis with the Nd:YAG laser. J Gynecol Surg 9:95\u201399. https:\/\/doi.org\/10.1089\/gyn.1993.9.95","journal-title":"J Gynecol Surg"},{"key":"7218_CR18","first-page":"722","volume":"68","author":"L Nappi","year":"2016","unstructured":"Nappi L, Sorrentino F, Angioni S et al (2016) The use of laser in hysteroscopic surgery. Minerva Ginecol 68:722\u2013726","journal-title":"Minerva Ginecol"},{"key":"7218_CR19","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/S00404-021-06154-Z","volume":"304","author":"S Angioni","year":"2021","unstructured":"Angioni S, Nappi L, Sorrentino F et al (2021) Laparoscopic treatment of deep endometriosis with a diode laser: our experience. Arch Gynecol Obstet 304:1221. https:\/\/doi.org\/10.1007\/S00404-021-06154-Z","journal-title":"Arch Gynecol Obstet"},{"key":"7218_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejogrb.2016.08.035","volume":"206","author":"L Nappi","year":"2016","unstructured":"Nappi L, Pontis A, Sorrentino F et al (2016) Hysteroscopic metroplasty for the septate uterus with diode laser: a pilot study. Eur J Obstet Gynecol Reprod Biol 206:32\u201335. https:\/\/doi.org\/10.1016\/j.ejogrb.2016.08.035","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"7218_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/S00404-016-4232-5","volume":"295","author":"L Nappi","year":"2017","unstructured":"Nappi L, Sorrentino F, Angioni S et al (2017) Feasibility of hysteroscopic endometrial polypectomy using a new dual wavelengths laser system (DWLS): preliminary results of a pilot study. Arch Gynecol Obstet 295:3\u20137. https:\/\/doi.org\/10.1007\/S00404-016-4232-5\/TABLES\/4","journal-title":"Arch Gynecol Obstet"},{"key":"7218_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/905204","author":"S Haimovich","year":"2015","unstructured":"Haimovich S, L\u00f3pez-Yarto M, Urresta \u00c1vila J et al (2015) Office Hysteroscopic laser enucleation of submucous myomas without mass extraction: a case series study. Biomed Res Int. https:\/\/doi.org\/10.1155\/2015\/905204","journal-title":"Biomed Res Int"},{"key":"7218_CR23","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3109\/09513590.2015.1105209","volume":"32","author":"MD Lara-Dom\u00ednguez","year":"2016","unstructured":"Lara-Dom\u00ednguez MD, Arjona-Berral JE, Dios-Palomares R, Castelo-Branco C (2016) Outpatient hysteroscopic polypectomy: bipolar energy system (Versapoint\u00ae) versus diode laser-randomized clinical trial. Gynecol Endocrinol 32:196\u2013200. https:\/\/doi.org\/10.3109\/09513590.2015.1105209","journal-title":"Gynecol Endocrinol"},{"key":"7218_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3109\/09513590.2015.1068754","volume":"32","author":"L Nappi","year":"2015","unstructured":"Nappi L, Angioni S, Sorrentino F et al (2015) Anti-Mullerian hormone trend evaluation after laparoscopic surgery of monolateral endometrioma using a new dual wavelengths laser system (DWLS) for hemostasis. Gynecol Endocrinol 32:34\u201337. https:\/\/doi.org\/10.3109\/09513590.2015.1068754","journal-title":"Gynecol Endocrinol"},{"key":"7218_CR25","doi-asserted-by":"publisher","first-page":"875","DOI":"10.31083\/j.ceog4804138","volume":"48","author":"MN D'Alterio","year":"2021","unstructured":"D\u2019Alterio MN, Scicchitano F, Fanni D et al (2021) Ex vivo myolysis with dual wavelengths diode laser system: macroscopic and histopathological examination. Clin Exp Obstet Gynecol 48:875\u2013882. https:\/\/doi.org\/10.31083\/j.ceog4804138","journal-title":"Clin Exp Obstet Gynecol"},{"key":"7218_CR26","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3390\/MEDICINA57050411","volume":"57","author":"F Sorrentino","year":"2021","unstructured":"Sorrentino F, De Feo V, Stabile G et al (2021) Cesarean scar pregnancy treated by artery embolization combined with diode laser: a novel approach for a rare disease. Medicina 57:411. https:\/\/doi.org\/10.3390\/MEDICINA57050411","journal-title":"Medicina"},{"key":"7218_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","volume":"4","author":"C Baethge","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S (2019) SANRA-a scale for the quality assessment of narrative review articles. Res Integr Peer Rev 4:5. https:\/\/doi.org\/10.1186\/s41073-019-0064-8","journal-title":"Res Integr Peer Rev"},{"key":"7218_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/J.IJGO.2010.11.011","volume":"113","author":"MG Munro","year":"2011","unstructured":"Munro MG, Critchley HOD, Broder MS, Fraser IS (2011) FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynecol Obstet 113:3\u201313. https:\/\/doi.org\/10.1016\/J.IJGO.2010.11.011","journal-title":"Int J Gynecol Obstet"},{"key":"7218_CR29","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/UOG.14806","volume":"46","author":"T Van Den Bosch","year":"2015","unstructured":"Van Den Bosch T, Dueholm M, Leone FPG et al (2015) Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group. Ultrasound Obstet Gynecol 46:284\u2013298. https:\/\/doi.org\/10.1002\/UOG.14806","journal-title":"Ultrasound Obstet Gynecol"},{"key":"7218_CR30","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1111\/HAE.12886","volume":"22","author":"S Halimeh","year":"2016","unstructured":"Halimeh S, Rott H, Kappert G (2016) PBAC score: an easy-to-use tool to predict coagulation disorders in women with idiopathic heavy menstrual bleeding. Haemophilia 22:e217\u2013e220. https:\/\/doi.org\/10.1111\/HAE.12886","journal-title":"Haemophilia"},{"key":"7218_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/J.EJOGRB.2010.05.012","volume":"152","author":"E Downes","year":"2010","unstructured":"Downes E, Sikirica V, Gilabert-Estelles J et al (2010) The burden of uterine fibroids in five European countries. Eur J Obstet Gynecol Reprod Biol 152:96\u2013102. https:\/\/doi.org\/10.1016\/J.EJOGRB.2010.05.012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"7218_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/AOG.0000000000001160","volume":"127","author":"BJ Borah","year":"2016","unstructured":"Borah BJ, Laughlin-Tommaso SK, Myers ER et al (2016) Association between patient characteristics and treatment procedure among patients with uterine leiomyomas. Obstet Gynecol 127:67. https:\/\/doi.org\/10.1097\/AOG.0000000000001160","journal-title":"Obstet Gynecol"},{"key":"7218_CR33","doi-asserted-by":"publisher","first-page":"319.e1","DOI":"10.1016\/J.AJOG.2013.07.017","volume":"209","author":"BJ Borah","year":"2013","unstructured":"Borah BJ, Nicholson WK, Bradley L, Stewart EA (2013) The impact of uterine leiomyomas: a national survey of affected women. Am J Obstet Gynecol 209:319.e1-319.e20. https:\/\/doi.org\/10.1016\/J.AJOG.2013.07.017","journal-title":"Am J Obstet Gynecol"},{"key":"7218_CR34","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jmig.2010.03.014","volume":"17","author":"SA Di Spiezio","year":"2010","unstructured":"Di Spiezio SA, Bettocchi S, Spinelli M et al (2010) review of new office-based hysteroscopic procedures 2003\u20132009. J Minim Invasive Gynecol 17:436\u2013448. https:\/\/doi.org\/10.1016\/j.jmig.2010.03.014","journal-title":"J Minim Invasive Gynecol"},{"key":"7218_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/HUMUPD\/DMM041","volume":"14","author":"SA Di Spiezio","year":"2008","unstructured":"Di Spiezio SA, Mazzon I, Bramante S et al (2008) Hysteroscopic myomectomy: a comprehensive review of surgical techniques. Hum Reprod Update 14:101\u2013119. https:\/\/doi.org\/10.1093\/HUMUPD\/DMM041","journal-title":"Hum Reprod Update"},{"key":"7218_CR36","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jmig.2013.11.007","volume":"21","author":"C Saccardi","year":"2014","unstructured":"Saccardi C, Conte L, Fabris A et al (2014) Hysteroscopic enucleation in toto of submucous type 2 myomas: long-term follow-up in women affected by menorrhagia. J Minim Invasive Gynecol 21:426\u2013430. https:\/\/doi.org\/10.1016\/j.jmig.2013.11.007","journal-title":"J Minim Invasive Gynecol"},{"key":"7218_CR37","first-page":"9S","volume":"99","author":"BB Lee","year":"2002","unstructured":"Lee BB (2002) Radiofrequency ablation of uterine leiomyomata: a new minimally invasive hysterectomy alternative. Obstet Gynecol 99:9S","journal-title":"Obstet Gynecol"},{"key":"7218_CR38","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jmig.2011.02.006","volume":"18","author":"JG Garza Leal","year":"2011","unstructured":"Garza Leal JG, Hernandez Leon I, Castillo Saenz L, Lee BB (2011) Laparoscopic ultrasound-guided radiofrequency volumetric thermal ablation of symptomatic uterine leiomyomas: feasibility study using the halt 2000 ablation system. J Minim Invasive Gynecol 18:364\u2013371. https:\/\/doi.org\/10.1016\/j.jmig.2011.02.006","journal-title":"J Minim Invasive Gynecol"},{"key":"7218_CR39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/J.IJGO.2012.07.023","volume":"120","author":"R Robles","year":"2013","unstructured":"Robles R, Aguirre VA, Argueta AI, Guerrero MR (2013) Laparoscopic radiofrequency volumetric thermal ablation of uterine myomas with 12 months of follow-up. Int J Gynecol Obstet 120:65\u201369. https:\/\/doi.org\/10.1016\/J.IJGO.2012.07.023","journal-title":"Int J Gynecol Obstet"},{"key":"7218_CR40","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/HUMREP\/DEQ366","volume":"26","author":"CH Kim","year":"2011","unstructured":"Kim CH, Kim SR, Lee HA et al (2011) Transvaginal ultrasound-guided radiofrequency myolysis for uterine myomas. Hum Reprod 26:559\u2013563. https:\/\/doi.org\/10.1093\/HUMREP\/DEQ366","journal-title":"Hum Reprod"},{"key":"7218_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/LAP.2018.0293","volume":"29","author":"VE Rey","year":"2019","unstructured":"Rey VE, Labrador R, Falcon M, Garcia-Benitez JL (2019) Transvaginal radiofrequency ablation of myomas: technique, outcomes, and complications. J Laparoendosc Adv Surg Tech 29:24\u201328. https:\/\/doi.org\/10.1089\/LAP.2018.0293","journal-title":"J Laparoendosc Adv Surg Tech"},{"key":"7218_CR42","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1177\/1933719114556481","volume":"22","author":"G Yin","year":"2015","unstructured":"Yin G, Chen M, Yang S et al (2015) Treatment of uterine myomas by radiofrequency thermal ablation: a 10-year retrospective cohort study. Reprod Sci 22:609. https:\/\/doi.org\/10.1177\/1933719114556481","journal-title":"Reprod Sci"},{"key":"7218_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejogrb.2014.03.017","volume":"177","author":"X Jiang","year":"2014","unstructured":"Jiang X, Thapa A, Lu J et al (2014) Ultrasound-guided transvaginal radiofrequency myolysis for symptomatic uterine myomas. Eur J Obstet Gynecol Reprod Biol 177:38\u201343. https:\/\/doi.org\/10.1016\/j.ejogrb.2014.03.017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"7218_CR44","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jmig.2022.01.011","volume":"29","author":"\u00c1 Santalla-Hern\u00e1ndez","year":"2022","unstructured":"Santalla-Hern\u00e1ndez \u00c1, Naveiro-Fuentes M, Benito-Villena R et al (2022) Efficacy, complications, and factors predictive of response to treatment with transvaginal radiofrequency ablation for symptomatic uterine myomas. J Minim Invasive Gynecol 29:743\u2013752. https:\/\/doi.org\/10.1016\/j.jmig.2022.01.011","journal-title":"J Minim Invasive Gynecol"},{"key":"7218_CR45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/S10397-014-0873-1","volume":"12","author":"M Bongers","year":"2015","unstructured":"Bongers M, Br\u00f6lmann H, Gupta J et al (2015) Transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the VizAblate\u00ae system: three- and six-month endpoint results from the FAST-EU study. Gynecol Surg 12:61. https:\/\/doi.org\/10.1007\/S10397-014-0873-1","journal-title":"Gynecol Surg"},{"key":"7218_CR46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/S10397-015-0915-3","volume":"13","author":"H Br\u00f6lmann","year":"2016","unstructured":"Br\u00f6lmann H, Bongers M, Garza-Leal JG et al (2016) The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids. Gynecol Surg 13:27\u201335. https:\/\/doi.org\/10.1007\/S10397-015-0915-3","journal-title":"Gynecol Surg"},{"key":"7218_CR47","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2147\/IJWH.S201912","volume":"11","author":"J Hudgens","year":"2019","unstructured":"Hudgens J, Johns DA, Lukes AS et al (2019) 12-month outcomes of the US patient cohort in the SONATA pivotal IDE trial of transcervical ablation of uterine fibroids. Int J Womens Health 11:387\u2013394. https:\/\/doi.org\/10.2147\/IJWH.S201912","journal-title":"Int J Womens Health"},{"key":"7218_CR48","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1089\/GYN.2019.0012","volume":"35","author":"CE Miller","year":"2019","unstructured":"Miller CE, Osman KM (2019) Transcervical radiofrequency ablation of symptomatic uterine fibroids: 2-year results of the SONATA pivotal trial. J Gynecol Surg 35:345. https:\/\/doi.org\/10.1089\/GYN.2019.0012","journal-title":"J Gynecol Surg"},{"key":"7218_CR49","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1089\/GYN.2020.0021","volume":"36","author":"A Lukes","year":"2020","unstructured":"Lukes A, Green MA (2020) Three-year results of the SONATA pivotal trial of transcervical fibroid ablation for symptomatic uterine myomata. J Gynecol Surg 36:228. https:\/\/doi.org\/10.1089\/GYN.2020.0021","journal-title":"J Gynecol Surg"},{"key":"7218_CR50","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1001\/JAMA.292.23.2826","volume":"292","author":"S Ringold","year":"2004","unstructured":"Ringold S (2004) FDA approves ultrasound fibroid therapy. JAMA 292:2826. https:\/\/doi.org\/10.1001\/JAMA.292.23.2826","journal-title":"JAMA"},{"key":"7218_CR51","doi-asserted-by":"publisher","first-page":"84","DOI":"10.12891\/CEOG3828.2018","volume":"45","author":"S Mascaretti","year":"2018","unstructured":"Mascaretti S, Ferrari F, Miccoli A et al (2018) Feasibility of magnetic resonance-guided focus ultrasound surgery (MRgFUS) in the uterine fibroid treatment: evaluation of the treatment radicalization in single and multiple fibroids correlated to clinical outcome. Clin Exp Obstet Gynecol 45:84\u201387. https:\/\/doi.org\/10.12891\/CEOG3828.2018\/PDF","journal-title":"Clin Exp Obstet Gynecol"},{"key":"7218_CR52","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1007\/S00330-019-06468-2","volume":"30","author":"JY Lee","year":"2020","unstructured":"Lee JY, Chung HH, Kang SY et al (2020) Portable ultrasound-guided high-intensity focused ultrasound with functions for safe and rapid ablation: prospective clinical trial for uterine fibroids\u2014short-term and long-term results. Eur Radiol 30:1554\u20131563. https:\/\/doi.org\/10.1007\/S00330-019-06468-2\/TABLES\/5","journal-title":"Eur Radiol"},{"key":"7218_CR53","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.7863\/ULTRA.33.10.1811","volume":"33","author":"JHY Leung","year":"2014","unstructured":"Leung JHY, Yu SCH, Cheung ECW et al (2014) Safety and efficacy of sonographically guided high-intensity focused ultrasound for symptomatic uterine fibroids: preliminary study of a modified protocol. J Ultrasound Med 33:1811\u20131818. https:\/\/doi.org\/10.7863\/ULTRA.33.10.1811","journal-title":"J Ultrasound Med"},{"key":"7218_CR54","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3109\/02656736.2015.1046406","volume":"31","author":"B Xie","year":"2015","unstructured":"Xie B, Zhang C, Xiong C et al (2015) High intensity focused ultrasound ablation for submucosal fibroids: a comparison between type I and type II. Int J Hyperthermia 31:593\u2013599. https:\/\/doi.org\/10.3109\/02656736.2015.1046406","journal-title":"Int J Hyperthermia"},{"key":"7218_CR55","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/S11604-007-0215-6","volume":"26","author":"K Mikami","year":"2008","unstructured":"Mikami K, Murakami T, Okada A et al (2008) Magnetic resonance imaging-guided focused ultrasound ablation of uterine fibroids: early clinical experience. Radiat Med 26:198\u2013205. https:\/\/doi.org\/10.1007\/S11604-007-0215-6\/METRICS","journal-title":"Radiat Med"},{"key":"7218_CR56","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jmig.2013.11.012","volume":"21","author":"Y Yang","year":"2014","unstructured":"Yang Y, Zhang J, Han yu Z et al (2014) Ultrasound-guided percutaneous microwave ablation for submucosal uterine fibroids. J Minim Invasive Gynecol 21:436\u2013441. https:\/\/doi.org\/10.1016\/j.jmig.2013.11.012","journal-title":"J Minim Invasive Gynecol"},{"key":"7218_CR57","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1080\/02656736.2016.1212276","volume":"32","author":"H Liu","year":"2016","unstructured":"Liu H, Zhang J, Han ZY et al (2016) Effectiveness of ultrasound-guided percutaneous microwave ablation for symptomatic uterine fibroids: a multicentre study in China. Int J Hyperthermia 32:876\u2013880. https:\/\/doi.org\/10.1080\/02656736.2016.1212276","journal-title":"Int J Hyperthermia"},{"key":"7218_CR58","doi-asserted-by":"publisher","first-page":"2154576","DOI":"10.1080\/02656736.2022.2154576","volume":"40","author":"M Lin","year":"2023","unstructured":"Lin M, He J, Lyu G et al (2023) Combined transabdominal and transvaginal ultrasound-guided percutaneous microwave ablation of uterine myomas: an effective monitoring technique. Int J Hyperthermia 40:2154576. https:\/\/doi.org\/10.1080\/02656736.2022.2154576","journal-title":"Int J Hyperthermia"},{"key":"7218_CR59","doi-asserted-by":"publisher","first-page":"5263","DOI":"10.1109\/EMBC44109.2020.9176092","volume":"2020","author":"G Zia","year":"2020","unstructured":"Zia G, Sebek J, Alvarez E, Prakash P (2020) Assessment of thermal damage to myometrium during microwave ablation of uterine fibroids. Annu Int Conf IEEE Eng Med Biol Soc 2020:5263\u20135266. https:\/\/doi.org\/10.1109\/EMBC44109.2020.9176092","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"7218_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13697137.2023.2205581","volume":"11","author":"SG Vitale","year":"2023","unstructured":"Vitale SG, Moore O, Riemma G et al (2023) Hysteroscopic laser ablation of symptomatic uterine fibroids: insights from a prospective study. Climacteric 11:1\u20136. https:\/\/doi.org\/10.1080\/1369713720232205581","journal-title":"Climacteric"},{"key":"7218_CR61","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/HUMUPD\/6.6.609","volume":"6","author":"J Donnez","year":"2000","unstructured":"Donnez J, Squifflet J, Polet R, Nisolle M (2000) Laparoscopic myolysis. Hum Reprod Update 6:609\u2013613. https:\/\/doi.org\/10.1093\/HUMUPD\/6.6.609","journal-title":"Hum Reprod Update"},{"key":"7218_CR62","doi-asserted-by":"publisher","first-page":"179.e1","DOI":"10.1016\/J.AJOG.2018.11.1086","volume":"220","author":"F Multinu","year":"2019","unstructured":"Multinu F, Casarin J, Tortorella L et al (2019) Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study. Am J Obstet Gynecol 220:179.e1-179.e10. https:\/\/doi.org\/10.1016\/J.AJOG.2018.11.1086","journal-title":"Am J Obstet Gynecol"},{"key":"7218_CR63","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ajog.2022.07.043","volume":"228","author":"SG Vitale","year":"2023","unstructured":"Vitale SG, Riemma G, Haimovich S et al (2023) Risk of endometrial cancer in asymptomatic postmenopausal women in relation to ultrasonographic endometrial thickness: systematic review and diagnostic test accuracy meta-analysis. Am J Obstet Gynecol 228:22-35.e2. https:\/\/doi.org\/10.1016\/j.ajog.2022.07.043","journal-title":"Am J Obstet Gynecol"},{"key":"7218_CR64","doi-asserted-by":"publisher","first-page":"e23540","DOI":"10.1200\/JCO.2020.38.15_suppl.e23540","volume":"38","author":"C Hana","year":"2020","unstructured":"Hana C, D\u2019Amato GZ (2020) Uterine sarcomas, insight into its risk factors: a systematic review. J Clin Oncol 38:e23540\u2013e23540. https:\/\/doi.org\/10.1200\/JCO.2020.38.15_suppl.e23540","journal-title":"J Clin Oncol"},{"key":"7218_CR65","doi-asserted-by":"publisher","first-page":"328","DOI":"10.12892\/ejgo24402014","volume":"35","author":"L Nappi","year":"2014","unstructured":"Nappi L, Mele G, Angioni S et al (2014) Uterine leiomyosarcoma: report of three cases and review of the literature. Eur J Gynaecol Oncol 35:328\u2013331. https:\/\/doi.org\/10.12892\/ejgo24402014","journal-title":"Eur J Gynaecol Oncol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-023-07218-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-023-07218-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-023-07218-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T13:08:02Z","timestamp":1707916082000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-023-07218-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":65,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["7218"],"URL":"https:\/\/doi.org\/10.1007\/s00404-023-07218-y","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,13]]},"assertion":[{"value":"5 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}